The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 17, 2015
Filed:
Oct. 15, 2009
Applicants:
Koji Masuda, Osaka, JP;
Shiro Kida, Osaka, JP;
Kyohei Hayashi, Osaka, JP;
Manabu Katou, Osaka, JP;
Naoki Yoshikawa, Osaka, JP;
Akira Kugimiya, Osaka, JP;
Mado Nakajima, Osaka, JP;
Nobuyuki Tanaka, Osaka, JP;
Inventors:
Koji Masuda, Osaka, JP;
Shiro Kida, Osaka, JP;
Kyohei Hayashi, Osaka, JP;
Manabu Katou, Osaka, JP;
Naoki Yoshikawa, Osaka, JP;
Akira Kugimiya, Osaka, JP;
Mado Nakajima, Osaka, JP;
Nobuyuki Tanaka, Osaka, JP;
Assignee:
Shionogi & Co., Ltd., Osaka-shi, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61K 31/428 (2006.01); C07D 513/02 (2006.01); C07D 513/04 (2006.01); C07D 235/16 (2006.01); A61K 31/4184 (2006.01); A61K 31/423 (2006.01); A61K 31/429 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); C07D 263/56 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 235/16 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/429 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); C07D 263/56 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01); C07D 513/04 (2013.01);
Abstract
Disclosed is a compound which is useful as an endothelial lipase inhibitor. A pharmaceutical composition having inhibitory activity on endothelial lipase comprising a compound represented by the formula: its pharmaceutically acceptable salt, or a solvate thereof,wherein